Calgranulin C (S100A12) is an innate immune peptide at the air–mucosal interface associated with neutrophil involvement, which when overexpressed has been implicated as a biomarker of inflammatory diseases. Decreased epithelial expression of certain innate immune peptides has been reported in chronic rhinosinusitis (CRS). We hypothesized that S100A12 is differentially expressed in the sinonasal mucosa of patients with CRS compared to controls and that S100A12 is a potential biomarker of CRS-specific quality of life (QOL) and disease severity.
Methods
A prospective observational study was conducted which included 70 patients: 17 controls, 28 having CRS without (CRSsNP), and 25 with (CRSwNP) nasal polyps. The expression of S100A12 and human neutrophil elastase (HNE) was assessed in the anterior ethmoid tissues from all patients using enzyme-linked immunosorbent assay (ELISA) and immunohistochemical (IHC) analyses. Disease-specific QOL (Rhinosinusitis Disability Index) and disease severity (computed tomography [CT] and endoscopy) were evaluated and correlated to the expression levels of S100A12.
Results
S100A12 and HNE were significantly elevated in patients with CRSsNP compared to normal controls (P < .05 and P < .001, respectively) and patients with CRSwNP (P < .05 and P < .001, respectively), as measured by ELISA and IHC analyses. Patients with CRS exhibited worse CRS-specific disease severity compared to normal controls (P < .05), and the increased protein levels of S100A12 were significantly correlated to disease severity, represented by CT scores (P < .05).
Conclusions
S100A12 is differentially expressed in CRS subtypes and is significantly elevated in patients with CRSsNP and associated with CRS-specific disease severity.
SchleimerRP.Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol. 2017;
12:331–357.
3.
LaneAPTruong-TranQASchleimerRP.Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps.Am J Rhinol. 2006;
20:138–144.
4.
DetwillerKYSmithTLAltJATruneDRMaceJCSautterNB.Differential expression of innate immunity genes in chronic rhinosinusitis.Am J Rhinol Allergy. 2014;
28:374–377.
5.
Van CrombruggenKJacobFZhangNBachertC.Damage-associated molecular patterns and their receptors in upper airway pathologies.Cell Mol Life Sci. 2013;
70:4307–4321.
6.
VoglTTenbrockKLudwigSet al.
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.Nat Med. 2007;
13:1042–1049.
7.
Van CrombruggenKHoltappelsGDe RuyckNDeryckeLTomassenPBachertC.RAGE processing in chronic airway conditions: involvement of Staphylococcus aureus and ECP.J Allergy Clin Immunol. 2012;
129:1515–1521.e1518.
8.
BrybornMAdnerMCardellLO.Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry.Respir Res. 2005;
6:118.
9.
HirschbergAKissMKadocsaEet al.
Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis.Eur Arch Otorhinolaryngol. 2016;
273:1779–1788.
10.
ShinSHYeMKKimYHKimJK.Role of TLRs in the production of chemical mediators in nasal polyp fibroblasts by fungi.Auris Nasus Larynx. 2016;
43:166–170.
11.
WangXJiWXuYGuoHZhaoC.[Expression and significance of Toll like receptor 2 and Toll like receptor 4 in chronic rhinosinusitis].Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;
28:1285–1288.
12.
FoellDFroschMSorgCRothJ.Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation.Clin Chim Acta. 2004;
344:37–51.
13.
KesselCHolzingerDFoellD.Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers.Clin Immunol. 2013;
147:229–241.
14.
RammesARothJGoebelerMKlemptMHartmannMSorgC.Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway.J Biol Chem. 1997;
272:9496–9502.
15.
UrbanCFErmertDSchmidMet al.
Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans.PLoS Pathog. 2009;
5:e1000639.
16.
BuhimschiCSBaumbuschMADulayATet al.
Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.Am J Pathol. 2009;
175:958–975.
17.
JungESChungWKimAJet al.
Associations between soluble receptor for advanced glycation end products (sRAGE) and S100A12 (EN-RAGE) with mortality in long-term hemodialysis patients.J Korean Med Sci. 2017;
32:54–59.
18.
ChengZDaiLLCaoDFet al.
[Changes of HMGB1 and RAGE in induced sputum from patients with bronchial asthma].Zhonghua Yi Xue Za Zhi. 2011;
91:1538–1542.
19.
RauvalaHRouhiainenA.RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease.Curr Mol Med. 2007;
7:725–734.
HofmannMADrurySFuCet al.
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.Cell. 1999;
97:889–901.
22.
TieuDDPetersATCarterRGet al.
Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis.J Allergy Clin Immunol. 2010;
125:667–675.
23.
Van CrombruggenKVoglTPerez-NovoCHoltappelsGBachertC.Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.Eur Respir J. 2016;
47:264–274.
24.
ChoSHHongSJHanBet al.
Age-related differences in the pathogenesis of chronic rhinosinusitis.J Allergy Clin Immunol. 2012;
129:858–860.e852.
25.
OesterleABowmanMA.S100A12 and the S100/calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets.Arterioscler Thromb Vasc Biol. 2015;
35:2496–2507.
26.
YamaokaMMaedaNNakamuraSet al.
Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (peripheral blood S100 mRNAs and metabolic syndrome).Biochem Biophys Res Commun. 2013;
433:450–455.
27.
LeachSTYangZMessinaIet al.
Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.Scand J Gastroenterol. 2007;
42:1321–1331.
28.
SidlerMALeachSTDayAS.Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.Inflamm Bowel Dis. 2008;
14:359–366.
29.
YanWXArmishawCGoyetteJet al.
Mast cell and monocyte recruitment by S100A12 and its hinge domain.J Biol Chem. 2008;
283:13035–13043.
30.
YangZTaoTRafteryMJYoussefPDi GirolamoNGeczyCL.Proinflammatory properties of the human S100 protein S100A12.J Leukoc Biol. 2001;
69:986–994.
31.
YangZYanWXCaiHet al.
S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity.J Allergy Clin Immunol. 2007;
119:106–114.
32.
RosenfeldRMAndesDBhattacharyyaNet al.
Clinical practice guideline: adult sinusitis.Otolaryngol Head Neck Surg. 2007;
137:S1–S31.
33.
BenningerMSSeniorBA.The development of the Rhinosinusitis Disability Index.Arch Otolaryngol Head Neck Surg. 1997;
123:1175–1179.
34.
LundVJMackayIS.Staging in rhinosinusitus.Rhinology. 1993;
31:183–184.
35.
LundVJKennedyDW.Staging for rhinosinusitis.Otolaryngol Head Neck Surg. 1997;
117:S35–S40.
36.
Van ZeleTClaeysSGevaertPet al.
Differentiation of chronic sinus diseases by measurement of inflammatory mediators.Allergy. 2006;
61:1280–1289.
37.
TomassenPVandeplasGVan ZeleTet al.
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.J Allergy Clin Immunol. 2016;
137:1449–1456.e1444.
38.
GittlerJKShemerASuarez-FarinasMet al.
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.J Allergy Clin Immunol. 2012;
130:1344–1354.
39.
WangKXuanXWangLet al.
[Expression and correlation analysis between inflammatory cytokines and calprotectin in the rat model of ulcerative colitis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;
30:278–280, 283.
40.
KoyMHambruchNHussenJPfarrerCSeyfertHMSchuberthHJ.Recombinant bovine S100A8 and A9 enhance IL-1beta secretion of interferon-gamma primed monocytes.Vet Immunol Immunopathol. 2013;
155:162–170.
41.
PhamDLYoonMGBanGYet al.
Serum S100A8 and S100A9 enhance innate immune responses in the pathogenesis of Baker’s asthma.Int Arch Allergy Immunol. 2015;
168:138–146.
42.
RamasamyRYanSFSchmidtAM.RAGE: therapeutic target and biomarker of the inflammatory response–the evidence mounts.J Leukoc Biol. 2009;
86:505–512.
43.
BellussiLMChenLChenDPassaliFMPassaliD.The role of High Mobility Group Box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis. Acta Otorhinolaryngolog Ital. 2012;
32:386–392.
44.
TardifMRChapeton-MontesJAPosvandzicAPageNGilbertCTessierPA.Secretion of S100A8, S100A9, and S100A12 by neutrophils involves reactive oxygen species and potassium efflux.J Immunol Res.
2015;2015:296149.
45.
WenWLiuWZhangLet al.
Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy.J Allergy Clin Immunol. 2012;
129:1522–1528.e1525.
46.
GoharFOrakBKallinichTet al.
Correlation of secretory activity of neutrophils with genotype in patients with familial Mediterranean fever.Arthritis Rheumatol. 2016;
68:3010–3022.
